California-Based Biotech Rallies Strongly Following $558.4M Divestiture
2024年12月4日 - 4:20AM
AllPennyStocks.com
A California-based biotech company found a
tremendous amount of success on Tuesday following the company
announcing an agreement to divest its Udenyca franchise for
$558.4...
To read the full story on AllPennyStocks.com, click
here.
Coherus BioSciences (NASDAQ:CHRS)
過去 株価チャート
から 11 2024 まで 12 2024
Coherus BioSciences (NASDAQ:CHRS)
過去 株価チャート
から 12 2023 まで 12 2024
